The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced.

Antonio VitielloRaffaele La PortaVilma D'AiutoFrancesco Ferrara

Published in: Egyptian liver journal (2021)

In this manuscript, we describe the clinical management aimed at preserving the liver or reducing the damage caused by COVID-19 and anti-COVID-19 drug treatments.

Keyphrases

drug induced
liver injury
sars cov
coronavirus disease
oxidative stress
respiratory syndrome coronavirus
adverse drug
diabetic rats
emergency department
human health
high glucose
stress induced
electronic health record